SHR-2150

N/A

Report date: 2022/05/26 14:30:36
NME

Base Information

Drug NameSHR-2150
Drug Alias NameSHR-2150SHR2150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsSolid tumoursHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co LtdSuzhou Suncadia Biopharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPla General HospitalJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A